Aminopyridinecarboxamides as CXCR2 modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE47740
SERIAL NO

15210803

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is disclosed id='REI-00001' date='20191126' aminopyridine- and aminopyrimidinecarboxamideid='REI-00001' id='REI-00002' date='20191126' aminopyridinecarboxamide id='REI-00002' compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include id='REI-00003' date='20191126' aminopyridine- and aminopyrimidinecarboxamidesid='REI-00003' id='REI-00004' date='20191126' aminopyridinecarboxamide id='REI-00004' compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTRIX BIOSYSTEMS INCAUBURN WA 98001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Maeda, Dean Y Seattle, US 19 121
Schuler, Aaron D Auburn, US 12 73
Zebala, John A Issaquah, US 38 403

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 26, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00